Citigroup’s LENZ Therapeutics LENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$43.9K Sell
4,801
-10,151
-68% -$143K ﹤0.01% 4570
2025
Q4
$239K Buy
14,952
+7,671
+105% +$224K ﹤0.01% 3915
2025
Q3
$339K Sell
7,281
-1,649
-18% -$60.6K ﹤0.01% 3759
2025
Q2
$262K Sell
8,930
-781
-8% -$21.2K ﹤0.01% 3937
2025
Q1
$250K Sell
9,711
-7,742
-44% -$191K ﹤0.01% 4066
2024
Q4
$504K Buy
17,453
+8,306
+91% +$253K ﹤0.01% 3823
2024
Q3
$217K Sell
9,147
-9,318
-50% -$207K ﹤0.01% 4283
2024
Q2
$319K Buy
18,465
+17,715
+2,362% +$309K ﹤0.01% 3651
2024
Q1
$16.7K Buy
750
+170
+29% +$3.53K ﹤0.01% 5084
2023
Q4
$10.6K Buy
580
+475
+452% +$7.84K ﹤0.01% 5183
2023
Q3
$1.82K Sell
105
-1,228
-92% -$21.4K ﹤0.01% 4988
2023
Q2
$24.3K Buy
1,333
+1,238
+1,303% +$24.7K ﹤0.01% 4912
2023
Q1
$1.62K Sell
95
-10,070
-99% -$163K ﹤0.01% 5113
2022
Q4
$236K Buy
10,165
+10,051
+8,817% +$233K ﹤0.01% 3635
2022
Q3
$3K Sell
114
-491
-81% -$11.7K ﹤0.01% 5428
2022
Q2
$12K Buy
605
+264
+77% +$5.88K ﹤0.01% 5297
2022
Q1
$12K Sell
341
-488
-59% -$30.5K ﹤0.01% 5452
2021
Q4
$72K Buy
829
+559
+207% +$46.3K ﹤0.01% 4903
2021
Q3
$31K Buy
+270
New +$40K ﹤0.01% 5014

Other funds holding LENZ